Today I’m joined by Dr. Juan Domínguez-Bendala, someone I know we’ll all be hearing a lot more about in the T1D world. He’s the Director of the Pancreatic Regeneration and Stem Cell Laboratory at the Diabetes Research Institute in Miami. His team just made headlines with a huge breakthrough: using a small peptide called THR-123 to regenerate insulin-producing beta cells in the pancreas. This could be an entirely new approach to treating, and even potentially reversing, type 1 diabetes. We know how emotional and complex the topic of a cure can be, and sometimes disheartening when updates are few and far between. That’s why sharing research-focused conversations like this matters so much– so our community can stay informed, feel seen, and keep hope alive for what’s happening behind the scenes. If this episode resonates with you, please share it so it can reach every person living with or impacted by T1D.
Quick Takeaways:
- The biggest breakthrough for a T1D cure that has been made in awhile: THR-123
- Milestones in diabetes research over the last two decades
- How this could shape the future of regenerative treatment for T1D
- Role of AI in diabetes research
- How to support diabetes research and stay informed
🔍Keep up with the Diabetes Research Institute 's cure-focused research & progress towards a cure by subscribing to their newsletter HERE.
📲Stay connected: Follow me @lauren_bongiorno and @riselyhealth on Instagram to stay in the loop when new episodes drop.
📩Send us a DM: Share your takeaways, questions about the episode and/or ideas for our next recording via direct message on IG to either account linked above.
💻Apply for coaching and talk to our team so you can reclaim the life you deserve.
📖Learn more about today’s topic.
